(VIANEWS) – Shares of Amicus Therapeutics (NASDAQ Composite: FOLD) rose 6.26% to $10.53 at 18:14 EST on Friday, following the last session’s downward trend. NASDAQ Composite is rising 0.05% to $14,942.83, following the last session’s downward trend. This seems, at the moment, a somewhat bullish trend exchanging session today.

Amicus Therapeutics’s last close was $9.91, 60.97% below its 52-week high of $25.39.


Today’s last reported volume for Amicus Therapeutics is 10587683 which is 323.07% above its average volume of 2502560.

The company’s growth estimates for the current quarter and the next is 28% and 33.3%, respectively.

Amicus Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 24.2%, now sitting on 281.82M for the twelve trailing months.


Amicus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.53%, a positive 0.34%, and a positive 2.63%, respectively.

Amicus Therapeutics’s highest amplitude of average volatility was 9.30% (last week), 3.64% (last month), and 2.63% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Amicus Therapeutics’s stock is considered to be oversold (<=20).

Amicus Therapeutics’s Stock Yearly Top and Bottom Value

Amicus Therapeutics’s stock is valued at $10.53 at 18:14 EST, way under its 52-week high of $25.39 and way higher than its 52-week low of $8.60.

Amicus Therapeutics’s Moving Average

Amicus Therapeutics’s value is under its 50-day moving average of $11.12 and higher than its 200-day moving average of $10.29.

More news about Amicus Therapeutics (FOLD).


Please enter your comment!
Please enter your name here